Latest Period
Q1 2026
Security Snapshot
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) Institutional Ownership
CUSIP: 525558201
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
338
Shares (Excl. Options)
22,124,607
Price
$109.17
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.01 Par Value
- Symbol
- LMAT on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 22,124,607
- Total 13F value
- $2,413,901,343
- Portfolio coverage rank
- 0%
- Share change
- +877,912
- Value change
- +$104,720,790
- Number of holders
- 338
- Shares outstanding
- 22,894,297
- SEC-reported price per share
- $100.83
- Insider filing price
- $100.83
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value is tracked under CUSIP 525558201.
- 338 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 297 to 338 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,727,874,826 to $2,413,901,343.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 338 institutions filings for Q1 2026.
Security key
525558201
Latest holder period
Q1 2026
13F holders
338
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
LMAT full holder history
LEMAITRE VASCULAR INC SEC filings
LEMAITRE VASCULAR INC company facts
LEMAITRE VASCULAR INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 525558201:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
LMAT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 14% | -21% | $287,330,114 | -$75,053,782 | 3,102,917 | -21% | BlackRock, Inc. | 31 Mar 2025 |
| Conestoga Capital Advisors, LLC | 8.1% | 0% | $123,875,714 | -$24,191,963 | 1,527,429 | -16% | Conestoga Capital Advisors | 31 Dec 2025 |
| LeMaitre George W | 6.4% | -15% | $159,945,053 | -$23,946,211 | 1,465,235 | -13% | George W. LeMaitre | 31 Mar 2026 |
| Copeland Capital Management, LLC | 5.2% | $91,579,548 | 988,980 | Copeland Capital Management | 31 Dec 2024 |
As of 31 Mar 2026, 338 institutional investors reported holding 22,124,607 shares of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT). This represents 97% of the company’s total 22,894,297 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14% | 3,144,151 | +0.38% | 0.01% | $343,246,976 |
| Conestoga Capital Advisors, LLC | 6.5% | 1,476,813 | +3.6% | 3.2% | $161,223,689 |
| FIRST TRUST ADVISORS LP | 4.4% | 998,071 | +6.2% | 0.08% | $108,959,411 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 912,058 | 0% | 0% | $99,569,372 |
| Copeland Capital Management, LLC | 3.8% | 870,692 | -2.1% | 2.1% | $95,053,549 |
| STATE STREET CORP | 3.7% | 855,784 | +6% | 0% | $93,425,939 |
| CONGRESS ASSET MANAGEMENT CO | 3.6% | 834,529 | +14% | 0.65% | $91,105,488 |
| GENEVA CAPITAL MANAGEMENT LLC | 3.3% | 753,992 | -7.4% | 1.7% | $82,313,260 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.9% | 658,445 | +4% | 0% | $71,893,244 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5% | 562,770 | 0% | 0% | $61,437,601 |
| DIMENSIONAL FUND ADVISORS LP | 2.1% | 476,335 | +0.1% | 0.01% | $51,999,066 |
| GOLDMAN SACHS GROUP INC | 1.9% | 432,416 | +11% | 0.01% | $47,206,860 |
| MORGAN STANLEY | 1.8% | 407,770 | -7.5% | 0% | $44,516,446 |
| Invesco Ltd. | 1.5% | 333,977 | +189% | 0.01% | $36,460,269 |
| NORTHERN TRUST CORP | 1.4% | 312,555 | -2.1% | 0% | $34,121,630 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.3% | 294,994 | +1.7% | 0% | $32,206,000 |
| TWO SIGMA INVESTMENTS, LP | 1.2% | 281,978 | +97% | 0.03% | $30,783,538 |
| ENVESTNET ASSET MANAGEMENT INC | 1.2% | 274,396 | +8.3% | 0.01% | $29,955,834 |
| ROYAL BANK OF CANADA | 1.2% | 272,654 | -6.3% | 0.01% | $29,765,000 |
| Annex Advisory Services, LLC | 1.1% | 250,610 | +2.8% | 0.51% | $27,359,081 |
| Ranger Investment Management, L.P. | 1% | 238,360 | -37% | 1.9% | $26,021,761 |
| KENNEDY CAPITAL MANAGEMENT LLC | 1% | 236,777 | -4.5% | 0.55% | $25,848,945 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1% | 230,718 | -6.5% | 0.07% | $25,187,484 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.86% | 197,975 | +0.84% | 0% | $21,612,931 |
| Driehaus Capital Management LLC | 0.86% | 197,225 | 0.16% | $21,531,053 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 22,124,607 | $2,413,901,343 | +$104,720,790 | $109.17 | 338 |
| 2025 Q4 | 21,303,414 | $1,727,874,826 | +$26,162,852 | $81.10 | 297 |
| 2025 Q3 | 20,972,168 | $1,835,216,297 | -$5,367,594 | $87.51 | 295 |
| 2025 Q2 | 21,166,185 | $1,758,234,218 | +$2,582,636 | $83.05 | 283 |
| 2025 Q1 | 21,153,493 | $1,775,213,757 | -$3,873,253 | $83.90 | 286 |
| 2024 Q4 | 21,174,653 | $1,951,282,055 | +$12,366,502 | $92.14 | 305 |
| 2024 Q3 | 20,982,696 | $1,948,703,180 | +$24,926,468 | $92.89 | 289 |
| 2024 Q2 | 20,545,327 | $1,690,376,215 | +$24,763,593 | $82.28 | 261 |
| 2024 Q1 | 20,244,067 | $1,343,284,255 | +$11,987,251 | $66.36 | 242 |
| 2023 Q4 | 20,084,131 | $1,139,986,402 | +$34,733,932 | $56.76 | 226 |
| 2023 Q3 | 19,480,544 | $1,061,371,614 | +$32,738,721 | $54.48 | 219 |
| 2023 Q2 | 18,811,526 | $1,264,888,648 | +$4,977,677 | $67.28 | 208 |
| 2023 Q1 | 18,807,566 | $968,037,117 | -$3,487,147 | $51.47 | 182 |
| 2022 Q4 | 19,244,139 | $885,480,684 | -$14,154,139 | $46.02 | 181 |
| 2022 Q3 | 19,520,595 | $989,204,894 | -$6,064,140 | $50.68 | 183 |
| 2022 Q2 | 19,290,567 | $878,994,108 | +$29,245,065 | $45.55 | 175 |
| 2022 Q1 | 18,775,944 | $872,420,057 | +$20,477,763 | $46.47 | 175 |
| 2021 Q4 | 18,437,180 | $924,595,207 | -$12,946,176 | $50.23 | 178 |
| 2021 Q3 | 18,624,446 | $989,044,311 | +$47,360,392 | $53.09 | 190 |
| 2021 Q2 | 17,706,224 | $1,079,385,907 | -$8,059,152 | $61.02 | 183 |
| 2021 Q1 | 17,933,078 | $875,505,917 | +$19,714,714 | $48.78 | 176 |
| 2020 Q4 | 17,703,794 | $717,764,963 | +$18,469,809 | $40.50 | 168 |
| 2020 Q3 | 17,300,958 | $562,850,201 | +$13,819,279 | $32.53 | 136 |
| 2020 Q2 | 16,847,952 | $444,929,145 | +$3,973,486 | $26.40 | 141 |
| 2020 Q1 | 16,762,310 | $417,910,467 | -$43,457,877 | $24.92 | 137 |